HealthTech: Early stage Alzheimer’s | Detecting diseases more quickly

  • PITTSBURGH, PA—Researchers from the University of Pittsburgh have just completed a study involving living patients that may bring hope to those with Alzheimer’s. The study findings suggest that targeting neuroinflammation might be beneficial for people with early-stage Alzheimer’s disease and that it might help reverse or at least slow down the accumulation of pathologic tau protein in the brain and stave off dementia.
  • WEST LAYFAYETTE, IN—Life sciences company Amplified Sciences, which is developing diagnostics designed to detect debilitating diseases more quickly, has closed on an $1.8 million seed round. Investors include Chicago-based OCA Ventures, Purdue Ventures, Indiana University Ventures, the IU Angel Network, New York-based Golden Seeds, Houston Angel Network, Chemical Angel Network in California, and Gravity Ventures in Indianapolis.